A single-arm, phase II feasibility study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma

被引：0
|
作者：
Ryu, M.
Choi, Y.
Kim, B.
Park, Y.
Kim, H.
Jung, H.
Lee, G.
Kim, K.
Yook, J.
Kang, Y.
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Diagnost Radiol, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.96
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
96
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma
    Park, Inkeun
    Ryu, Min-Hee
    Choi, Yoon Hee
    Kang, Hyo Jeong
    Yook, Jeong Hwan
    Park, Young Soo
    Kim, Hyun Jin
    Jung, Hwoon-Yong
    Lee, Gin Hyug
    Kim, Kab Choong
    Kim, Byung Sik
    Kang, Yoon-Koo
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 815 - 823
  • [2] A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma
    Inkeun Park
    Min-Hee Ryu
    Yoon Hee Choi
    Hyo Jeong Kang
    Jeong Hwan Yook
    Young Soo Park
    Hyun Jin Kim
    Hwoon-Yong Jung
    Gin Hyug Lee
    Kab Choong Kim
    Byung Sik Kim
    Yoon-Koo Kang
    [J]. Cancer Chemotherapy and Pharmacology, 2013, 72 : 815 - 823
  • [3] Neoadjuvant docetaxel, oxaliplatin and S-1 (DOS) combination chemotherapy for patients with resectable adenocarcinoma of esophagogastric junction
    Saito, Takuro
    Kurokawa, Yukinori
    Takahashi, Tsuyoshi
    Yamamoto, Kazuyoshi
    Yamashita, Kotaro
    Tanaka, Koji
    Makino, Tomoki
    Nakajima, Kiyokazu
    Eguchi, Hidetoshi
    Doki, Yuichiro
    [J]. GASTRIC CANCER, 2022, 25 (05) : 966 - 972
  • [4] Neoadjuvant docetaxel, oxaliplatin and S‑1 (DOS) combination chemotherapy for patients with resectable adenocarcinoma of esophagogastric junction
    Takuro Saito
    Yukinori Kurokawa
    Tsuyoshi Takahashi
    Kazuyoshi Yamamoto
    Kotaro Yamashita
    Koji Tanaka
    Tomoki Makino
    Kiyokazu Nakajima
    Hidetoshi Eguchi
    Yuichiro Doki
    [J]. Gastric Cancer, 2022, 25 : 966 - 972
  • [5] Efficacy and safety of camrelizumab combined with oxaliplatin and S-1 as neoadjuvant treatment in locally advanced gastric or gastroesophageal junction cancer: A phase II, single-arm study
    Zhong, Wen-Jin
    Lin, Jian-An
    Wu, Chu-Ying
    Wang, Jiantian
    Chen, Jun-Xing
    Zheng, Huida
    Ye, Kai
    [J]. CANCER MEDICINE, 2024, 13 (03):
  • [6] A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction
    Kei Hosoda
    Mizutomo Azuma
    Chikatoshi Katada
    Kenji Ishido
    Masahiro Niihara
    Hideki Ushiku
    Mikiko Sakuraya
    Marie Washio
    Takuya Wada
    Akinori Watanabe
    Hiroki Harada
    Satoshi Tanabe
    Wasaburo Koizumi
    Keishi Yamashita
    Naoki Hiki
    [J]. International Journal of Clinical Oncology, 2020, 25 : 1090 - 1097
  • [7] A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction
    Hosoda, Kei
    Azuma, Mizutomo
    Katada, Chikatoshi
    Ishido, Kenji
    Niihara, Masahiro
    Ushiku, Hideki
    Sakuraya, Mikiko
    Washio, Marie
    Wada, Takuya
    Watanabe, Akinori
    Harada, Hiroki
    Tanabe, Satoshi
    Koizumi, Wasaburo
    Yamashita, Keishi
    Hiki, Naoki
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (06) : 1090 - 1097
  • [8] A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction
    Hosoda, K.
    Azuma, M.
    Katada, C.
    Ishido, K.
    Niihara, M.
    Ushiku, H.
    Sakuraya, M.
    Washio, M.
    Wada, T.
    Watanabe, A.
    Harada, H.
    Tanabe, S.
    Koizumi, W.
    Yamashita, K.
    Hiki, N.
    Watanabe, M.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [9] PHASE II STUDY WITH DOCETAXEL, OXALIPLATIN AND S-1 (DOS) COMBINATION CHEMOTHERAPY FOR PATIENTS WITH METASTATIC GASTRIC CANCE
    Zang, D.
    Kang, Y.
    Ryoo, B.
    Ryu, M.
    Lee, S.
    Song, H.
    Kim, H.
    Jung, J.
    Kim, J.
    Kwon, J.
    Jang, G.
    Kim, H.
    Lee, Y.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 89 - 89
  • [10] Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma
    Honma, Yoshitaka
    Yamada, Yasuhide
    Terazawa, Tetsuji
    Takashima, Atsuo
    Iwasa, Satoru
    Kato, Ken
    Hamaguchi, Tetsuya
    Shimada, Yasuhiro
    Ohashi, Masaki
    Morita, Shinji
    Fukagawa, Takeo
    Machida, Nozomu
    Katai, Hitoshi
    [J]. SURGERY TODAY, 2016, 46 (09) : 1076 - 1082
12345